{"doi":"10.1016/j.clinthera.2012.03.029","title":"Children With Fabry Disease","abstract":null,"journal":"Clinical Therapeutics","year":2012,"id":14167,"datarank":0.11035303488337037,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.006380957799378558,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.006380957799378558,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":1,"citers_with_citation_signal":1,"citers_with_endowment":1,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":113139,"name":"Uma Ramaswami","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21071399","pmcid":null,"openalex_id":"https://openalex.org/W2021717101","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.10714934,"influential_citations":0,"citation_trend":[{"year":2024,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0149291812001798?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0149291812001798?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.clinthera.2012.03.029","host_type":"journal"}],"fields_of_study":["Lysosomal Storage Disorders Research","Carbohydrate Chemistry and Synthesis","Biomedical Research and Pathophysiology","Medicine"],"mesh_terms":[],"keywords":["Globotriaosylceramide","Fabry disease","Lysosomal storage disease","Medicine","Fabry's disease","Heterozygote advantage","Disease","Alpha-galactosidase","Enzyme replacement therapy","Glucocerebrosidase","Enzyme","Internal medicine","Gene","Genetics","Biochemistry","Biology","Genotype"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-01T05:20:58.058854Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}